Louise A. Carolan
792 Elizabeth St
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses.
Journal: Science translational medicine
Published: April 01, 2026
Immunogenicity of high-dose recombinant influenza vaccine versus standard-dose egg-grown and cell-grown vaccines among frequently and infrequently vaccinated young adults in Singapore: a randomised, controlled, double-blind, single-centre, phase 4 clinical trial.
Journal: The Lancet. Infectious diseases
Published: September 16, 2025
Influenza vaccine responses differ between young children previously exposed to influenza antigens via infection versus vaccination.
Journal: Communications medicine
Published: July 08, 2025
Boosting the influenza vaccine schedule in children with cancer: a prospective open-label study.
Journal: NPJ vaccines
Published: May 27, 2025
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial.
Journal: The Journal of infectious diseases
Published: January 16, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 28, 2024
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohort.
Journal: Research square
Published: October 07, 2024
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.
Journal: Frontiers in immunology
Published: August 27, 2024
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.
Journal: medRxiv : the preprint server for health sciences
Published: July 23, 2024
Last Updated: 09/26/2026